Background: Rosa damascena, a type of herb, has been used for wound healing in Eastern folk medicine. The goal of this study was to evaluate the effectiveness of rose placenta from R. damascena in a full-thickness wound model in mice.
Methods: Sixty six-week-old C57BL/6N mice were used. Full-thickness wounds were made with an 8-mm diameter punch. Two wounds were made on each side of the back, and wounds were assigned randomly to the control and experimental groups. Rose placenta (250 µg) was injected in the experimental group, and normal saline was injected in the control group. Wound sizes were measured with digital photography, and specimens were harvested. Immunohistochemical staining was performed to assess the expression of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and CD31. Vessel density was measured. Quantitative analysis using an enzyme-linked immunosorbent assay (ELISA) for EGF was performed. All evaluations were performed on postoperative days 0, 2, 4, 7, and 10. Statistical analyses were performed using the paired t-test.
Results: On days 4, 7, and 10, the wounds treated with rose placenta were significantly smaller. On day 2, VEGF and EGF expression increased in the experimental group. On days 7 and 10, TGF-β1 expression decreased in the experimental group. On day 10, vessel density increased in the experimental group. The increase in EGF on day 2 was confirmed with ELISA.
Conclusions: Rose placenta was found to be associated with improved wound healing in a mouse full-thickness wound model via increased EGF release. Rose placenta may potentially be a novel drug candidate for enhancing wound healing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659980 | PMC |
| http://dx.doi.org/10.5999/aps.2015.42.6.686 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Seroprevalence and risk factors of brucellosis in pastoralists and their livestock in Central Equatoria State, South Sudan.
PLoS Negl Trop Dis
December 2024
Department of Veterinary Anatomy and Pathology, College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Morogoro, Tanzania.
Background: Brucellosis poses serious public health implications and substantial economic losses in pastoral rural settings in South Sudan. In humans, brucellosis is almost always originating from animals. Current literature provides scant data regarding the seroprevalence of brucellosis in South Sudan.
View Article and Find Full Text PDFComprehensive study on human brucellosis seroprevalence and Brucella species distribution in Iran (1970-2023).
Microb Pathog
January 2025
Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Brucellosis is a zoonotic bacterial disease that causes enormous economic losses in livestock populations and severe debilitation in humans globally. This study analyzes the seroprevalence of human brucellosis in Iran from 1970 to 2023, revealing key epidemiological trends based on data from 20,046 individuals. Through serological, culture, and molecular tests, it identifies the Brucella species affecting humans over five decades.
View Article and Find Full Text PDFComparative efficacy and safety between intravenous labetalol and intravenous hydralazine for hypertensive disorders in pregnancy: A systematic review and meta-analysis of 19 randomized controlled trials.
Eur J Obstet Gynecol Reprod Biol
December 2024
Federal University of Roraima, Boa Vista, Roraima, Brazil.
Article Synopsis
- Hypertensive disorders in pregnancy can lead to serious complications, prompting the need for medication such as hydralazine and labetalol to lower blood pressure.
- A systematic review of 19 randomized controlled trials compared the effectiveness and safety of intravenous labetalol versus hydralazine in managing these conditions.
- The findings indicated no significant differences in blood pressure outcomes between the two medications, but labetalol was found to significantly reduce instances of maternal hypotension compared to hydralazine.
Maternal and fetal outcomes among pregnant women with endometriosis.
J Perinat Med
November 2024
Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Article Synopsis
- The study investigates the link between endometriosis during pregnancy and negative health outcomes for mothers and newborns, using data from the Healthcare Cost and Utilization Project over a 20-year period.
- Findings show a significant increase in endometriosis prevalence during pregnancy and reveal that mothers with endometriosis face higher risks of complications such as pre-eclampsia, gestational diabetes, and preterm birth, while their newborns may experience growth restrictions and congenital anomalies.
- The study emphasizes the need for healthcare providers to monitor pregnancies of individuals with endometriosis closely due to the heightened risk of adverse events associated with this condition.
hsa-miR-582-3p in umbilical cord blood is negatively associated with maternal exposure to childhood maltreatment.
Epigenomics
October 2024
Department of Morphology & Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
Article Synopsis
- Childhood maltreatment (CM) can affect the children of those who experienced it, and the biological processes behind this are not well understood.
- This study examined how maternal experiences of CM relate to the expression of microRNAs (miRNAs) in maternal and perinatal tissues by analyzing samples from 43 pregnant women.
- It found that higher levels of maternal CM were linked to lower levels of a specific miRNA (hsa-miR-582-3p) in cord blood, suggesting a potential impact on the genetic development of the offspring.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!